 Swati Patel
Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colorectal Neoplasms | 41 | 2025 | 806 | 10.270 |
Why?
| | Colonoscopy | 31 | 2025 | 245 | 8.130 |
Why?
| | Colonic Polyps | 13 | 2025 | 88 | 6.140 |
Why?
| | Early Detection of Cancer | 21 | 2024 | 447 | 5.360 |
Why?
| | Gastroenterology | 12 | 2025 | 180 | 4.570 |
Why?
| | Clinical Competence | 12 | 2025 | 1118 | 2.500 |
Why?
| | Adenomatous Polyps | 3 | 2020 | 10 | 1.810 |
Why?
| | Adenoma | 5 | 2024 | 230 | 1.310 |
Why?
| | Colorectal Neoplasms, Hereditary Nonpolyposis | 3 | 2020 | 35 | 1.270 |
Why?
| | Intestinal Polyposis | 4 | 2022 | 7 | 1.200 |
Why?
| | Adenocarcinoma | 5 | 2022 | 940 | 1.140 |
Why?
| | Narrow Band Imaging | 3 | 2019 | 14 | 1.050 |
Why?
| | Mass Screening | 12 | 2024 | 1287 | 1.020 |
Why?
| | Precancerous Conditions | 2 | 2021 | 169 | 1.020 |
Why?
| | Endoscopy, Digestive System | 3 | 2020 | 136 | 1.000 |
Why?
| | Helminths | 1 | 2025 | 9 | 0.950 |
Why?
| | Helminthiasis | 1 | 2025 | 12 | 0.940 |
Why?
| | Anthelmintics | 1 | 2025 | 11 | 0.940 |
Why?
| | Risk Assessment | 6 | 2022 | 3457 | 0.920 |
Why?
| | Biological Evolution | 3 | 2025 | 474 | 0.920 |
Why?
| | Incidence | 11 | 2024 | 2804 | 0.920 |
Why?
| | Competency-Based Education | 2 | 2015 | 73 | 0.900 |
Why?
| | Self-Assessment | 1 | 2025 | 72 | 0.890 |
Why?
| | Drug Resistance | 1 | 2025 | 169 | 0.890 |
Why?
| | Appendiceal Neoplasms | 2 | 2022 | 27 | 0.880 |
Why?
| | Soil | 1 | 2025 | 230 | 0.800 |
Why?
| | Age of Onset | 6 | 2022 | 518 | 0.800 |
Why?
| | Neoplastic Syndromes, Hereditary | 4 | 2022 | 44 | 0.800 |
Why?
| | Humans | 71 | 2025 | 137585 | 0.780 |
Why?
| | Fellowships and Scholarships | 3 | 2021 | 306 | 0.760 |
Why?
| | Crassostrea | 1 | 2021 | 1 | 0.740 |
Why?
| | Gills | 1 | 2021 | 4 | 0.740 |
Why?
| | Petroleum Pollution | 1 | 2021 | 10 | 0.730 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2022 | 58 | 0.710 |
Why?
| | Cathartics | 3 | 2025 | 15 | 0.700 |
Why?
| | Aftercare | 1 | 2023 | 208 | 0.700 |
Why?
| | Education, Medical, Graduate | 2 | 2015 | 486 | 0.680 |
Why?
| | Utilization Review | 1 | 2020 | 36 | 0.670 |
Why?
| | Hamartoma Syndrome, Multiple | 4 | 2022 | 17 | 0.660 |
Why?
| | Genes, APC | 1 | 2020 | 12 | 0.660 |
Why?
| | Intestinal Polyps | 4 | 2022 | 17 | 0.650 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2020 | 1329 | 0.630 |
Why?
| | Gastrointestinal Tract | 1 | 2021 | 195 | 0.610 |
Why?
| | Hospitals, Veterans | 1 | 2020 | 252 | 0.610 |
Why?
| | Risk Factors | 12 | 2024 | 10388 | 0.590 |
Why?
| | Curriculum | 2 | 2015 | 992 | 0.590 |
Why?
| | Stomach Neoplasms | 1 | 2020 | 122 | 0.580 |
Why?
| | Peutz-Jeghers Syndrome | 3 | 2022 | 10 | 0.580 |
Why?
| | Telangiectasia, Hereditary Hemorrhagic | 3 | 2022 | 13 | 0.570 |
Why?
| | Hamartoma | 3 | 2022 | 22 | 0.570 |
Why?
| | Genetic Testing | 3 | 2022 | 460 | 0.570 |
Why?
| | Surgeons | 1 | 2022 | 297 | 0.560 |
Why?
| | Patient Discharge | 2 | 2023 | 897 | 0.550 |
Why?
| | Societies, Medical | 1 | 2022 | 820 | 0.550 |
Why?
| | Practice Guidelines as Topic | 3 | 2022 | 1587 | 0.530 |
Why?
| | Quality Assurance, Health Care | 1 | 2019 | 322 | 0.520 |
Why?
| | United States | 16 | 2025 | 14841 | 0.520 |
Why?
| | Learning Curve | 4 | 2024 | 72 | 0.510 |
Why?
| | Middle Aged | 20 | 2024 | 33479 | 0.500 |
Why?
| | Gastrointestinal Hemorrhage | 5 | 2023 | 132 | 0.490 |
Why?
| | Guideline Adherence | 1 | 2020 | 556 | 0.480 |
Why?
| | Genetic Counseling | 1 | 2016 | 77 | 0.470 |
Why?
| | Age Factors | 6 | 2022 | 3295 | 0.450 |
Why?
| | Predictive Value of Tests | 4 | 2021 | 2031 | 0.440 |
Why?
| | Adult | 18 | 2025 | 37929 | 0.430 |
Why?
| | Genetic Predisposition to Disease | 6 | 2024 | 2426 | 0.430 |
Why?
| | Ecosystem | 2 | 2020 | 596 | 0.410 |
Why?
| | Polyps | 1 | 2013 | 11 | 0.410 |
Why?
| | DNA Glycosylases | 1 | 2012 | 8 | 0.400 |
Why?
| | Female | 26 | 2025 | 73304 | 0.380 |
Why?
| | Male | 24 | 2025 | 67762 | 0.370 |
Why?
| | Formative Feedback | 2 | 2024 | 28 | 0.330 |
Why?
| | Models, Biological | 1 | 2017 | 1783 | 0.330 |
Why?
| | Education, Medical | 1 | 2013 | 266 | 0.320 |
Why?
| | Anesthesiology | 1 | 2009 | 87 | 0.270 |
Why?
| | Occult Blood | 2 | 2024 | 34 | 0.270 |
Why?
| | Mutation | 4 | 2024 | 3958 | 0.260 |
Why?
| | Benchmarking | 2 | 2020 | 186 | 0.250 |
Why?
| | Aged, 80 and over | 4 | 2021 | 7635 | 0.240 |
Why?
| | Consensus | 3 | 2025 | 683 | 0.240 |
Why?
| | Singapore | 1 | 2025 | 22 | 0.230 |
Why?
| | Wiskott-Aldrich Syndrome Protein | 1 | 2024 | 4 | 0.230 |
Why?
| | Wiskott-Aldrich Syndrome | 1 | 2024 | 4 | 0.230 |
Why?
| | Life Cycle Stages | 1 | 2025 | 41 | 0.230 |
Why?
| | Prospective Studies | 5 | 2024 | 7604 | 0.220 |
Why?
| | Aged | 8 | 2024 | 23961 | 0.210 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2024 | 89 | 0.210 |
Why?
| | Computer-Assisted Instruction | 1 | 2024 | 66 | 0.210 |
Why?
| | Carcinoid Tumor | 1 | 2022 | 26 | 0.200 |
Why?
| | Calcitriol | 1 | 2022 | 58 | 0.190 |
Why?
| | Educational Measurement | 1 | 2025 | 289 | 0.190 |
Why?
| | Surgical Instruments | 1 | 2022 | 51 | 0.190 |
Why?
| | Neoplasms | 3 | 2023 | 2671 | 0.190 |
Why?
| | Gulf of Mexico | 1 | 2021 | 4 | 0.190 |
Why?
| | Ecotoxicology | 1 | 2021 | 3 | 0.190 |
Why?
| | Trypanosomiasis, African | 1 | 2021 | 3 | 0.180 |
Why?
| | Metaplasia | 1 | 2021 | 60 | 0.180 |
Why?
| | Alleles | 3 | 2022 | 891 | 0.180 |
Why?
| | North America | 1 | 2022 | 313 | 0.180 |
Why?
| | Simethicone | 3 | 2025 | 3 | 0.180 |
Why?
| | Europe | 1 | 2022 | 414 | 0.180 |
Why?
| | Stomach | 1 | 2021 | 110 | 0.180 |
Why?
| | Sensitivity and Specificity | 2 | 2024 | 1946 | 0.170 |
Why?
| | Documentation | 1 | 2023 | 194 | 0.170 |
Why?
| | Preventive Medicine | 1 | 2021 | 42 | 0.170 |
Why?
| | Artificial Intelligence | 1 | 2024 | 279 | 0.170 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2023 | 228 | 0.170 |
Why?
| | Pediatrics | 1 | 2009 | 1101 | 0.170 |
Why?
| | Video Recording | 2 | 2019 | 180 | 0.170 |
Why?
| | Colonic Neoplasms | 1 | 2022 | 258 | 0.160 |
Why?
| | Endoscopy | 1 | 2022 | 318 | 0.160 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2022 | 437 | 0.160 |
Why?
| | Carcinoma | 1 | 2021 | 240 | 0.160 |
Why?
| | Diarrhea | 1 | 2020 | 184 | 0.160 |
Why?
| | Accreditation | 2 | 2020 | 83 | 0.150 |
Why?
| | Syndrome | 1 | 2020 | 358 | 0.150 |
Why?
| | Environmental Monitoring | 1 | 2021 | 370 | 0.150 |
Why?
| | Clinical Decision-Making | 1 | 2021 | 322 | 0.150 |
Why?
| | Water Pollutants, Chemical | 1 | 2021 | 215 | 0.140 |
Why?
| | Vincristine | 1 | 2018 | 116 | 0.140 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2018 | 80 | 0.140 |
Why?
| | Health Literacy | 1 | 2020 | 168 | 0.140 |
Why?
| | Mathematical Concepts | 1 | 2017 | 31 | 0.140 |
Why?
| | Congresses as Topic | 1 | 2019 | 233 | 0.140 |
Why?
| | Immunomodulation | 1 | 2018 | 98 | 0.140 |
Why?
| | Feedback, Physiological | 1 | 2017 | 77 | 0.140 |
Why?
| | Peripheral Nervous System Diseases | 1 | 2018 | 128 | 0.140 |
Why?
| | Risk | 2 | 2020 | 912 | 0.140 |
Why?
| | Delphi Technique | 1 | 2019 | 280 | 0.140 |
Why?
| | Animals | 5 | 2025 | 36940 | 0.130 |
Why?
| | Portal Vein | 1 | 2018 | 120 | 0.130 |
Why?
| | Bile Duct Neoplasms | 1 | 2018 | 124 | 0.130 |
Why?
| | Population Dynamics | 1 | 2017 | 151 | 0.130 |
Why?
| | Cost-Benefit Analysis | 1 | 2019 | 591 | 0.130 |
Why?
| | Genetic Association Studies | 1 | 2017 | 377 | 0.120 |
Why?
| | Phenotype | 2 | 2024 | 3196 | 0.120 |
Why?
| | Diagnosis, Differential | 1 | 2020 | 1483 | 0.120 |
Why?
| | Life Style | 1 | 2018 | 490 | 0.120 |
Why?
| | Promoter Regions, Genetic | 1 | 2020 | 1250 | 0.120 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 289 | 0.120 |
Why?
| | Program Evaluation | 2 | 2020 | 898 | 0.110 |
Why?
| | Patient Education as Topic | 1 | 2020 | 766 | 0.110 |
Why?
| | Magnetic Resonance Imaging, Cine | 2 | 2014 | 193 | 0.110 |
Why?
| | Tertiary Care Centers | 1 | 2015 | 160 | 0.110 |
Why?
| | Task Performance and Analysis | 1 | 2015 | 183 | 0.110 |
Why?
| | Colorectal Surgery | 1 | 2014 | 24 | 0.110 |
Why?
| | Electronic Health Records | 1 | 2022 | 1069 | 0.110 |
Why?
| | Prevalence | 1 | 2021 | 2734 | 0.110 |
Why?
| | Early Diagnosis | 1 | 2015 | 242 | 0.110 |
Why?
| | Arthritis, Rheumatoid | 1 | 2022 | 1167 | 0.100 |
Why?
| | Retrospective Studies | 2 | 2022 | 15657 | 0.100 |
Why?
| | Primary Prevention | 1 | 2015 | 196 | 0.100 |
Why?
| | Genetic Variation | 1 | 2018 | 991 | 0.100 |
Why?
| | Image Enhancement | 1 | 2014 | 190 | 0.100 |
Why?
| | Histocytochemistry | 1 | 2013 | 80 | 0.100 |
Why?
| | Odds Ratio | 1 | 2015 | 1070 | 0.100 |
Why?
| | Magnetic Resonance Angiography | 1 | 2014 | 240 | 0.100 |
Why?
| | Data Collection | 1 | 2015 | 673 | 0.090 |
Why?
| | Multivariate Analysis | 1 | 2015 | 1509 | 0.090 |
Why?
| | Cell Adhesion Molecules | 1 | 2012 | 181 | 0.090 |
Why?
| | Internship and Residency | 1 | 2021 | 1147 | 0.090 |
Why?
| | SEER Program | 2 | 2022 | 227 | 0.090 |
Why?
| | Biomarkers, Tumor | 1 | 2017 | 1276 | 0.090 |
Why?
| | Reproducibility of Results | 2 | 2015 | 3284 | 0.080 |
Why?
| | Logistic Models | 1 | 2015 | 2074 | 0.080 |
Why?
| | Pancreatic Neoplasms | 1 | 2018 | 938 | 0.080 |
Why?
| | Veterans | 1 | 2021 | 1476 | 0.080 |
Why?
| | Health Promotion | 1 | 2016 | 741 | 0.080 |
Why?
| | Organization and Administration | 1 | 2009 | 12 | 0.080 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 1692 | 0.070 |
Why?
| | Anesthesia, General | 1 | 2009 | 77 | 0.070 |
Why?
| | Analgesia | 1 | 2009 | 94 | 0.070 |
Why?
| | Monitoring, Physiologic | 1 | 2009 | 275 | 0.060 |
Why?
| | Heart Defects, Congenital | 1 | 2014 | 842 | 0.060 |
Why?
| | Young Adult | 2 | 2020 | 13209 | 0.060 |
Why?
| | Twins, Conjoined | 1 | 2004 | 5 | 0.060 |
Why?
| | India | 1 | 2024 | 195 | 0.060 |
Why?
| | Surgery, Plastic | 1 | 2004 | 45 | 0.050 |
Why?
| | DNA Mutational Analysis | 1 | 2024 | 399 | 0.050 |
Why?
| | Skull | 1 | 2004 | 139 | 0.050 |
Why?
| | Receptors, CCR7 | 1 | 2022 | 32 | 0.050 |
Why?
| | Microsurgery | 1 | 2023 | 75 | 0.050 |
Why?
| | Child | 4 | 2024 | 21935 | 0.050 |
Why?
| | Appendectomy | 1 | 2022 | 79 | 0.050 |
Why?
| | Trypanosoma brucei gambiense | 1 | 2021 | 1 | 0.050 |
Why?
| | Oncogenes | 1 | 2022 | 116 | 0.050 |
Why?
| | Democratic Republic of the Congo | 1 | 2021 | 30 | 0.050 |
Why?
| | Methotrexate | 1 | 2022 | 260 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2023 | 5472 | 0.040 |
Why?
| | Liposomes | 1 | 2022 | 223 | 0.040 |
Why?
| | Patient Preference | 1 | 2022 | 191 | 0.040 |
Why?
| | Immunologic Factors | 1 | 2022 | 236 | 0.040 |
Why?
| | Probability | 1 | 2021 | 304 | 0.040 |
Why?
| | Rectal Neoplasms | 1 | 2021 | 149 | 0.040 |
Why?
| | Collagen | 1 | 2022 | 452 | 0.040 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2022 | 366 | 0.040 |
Why?
| | Feedback | 1 | 2019 | 173 | 0.040 |
Why?
| | NF-kappa B | 1 | 2022 | 691 | 0.040 |
Why?
| | Infant | 3 | 2024 | 9465 | 0.040 |
Why?
| | Decision Support Techniques | 1 | 2022 | 421 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2022 | 718 | 0.040 |
Why?
| | INDEL Mutation | 1 | 2017 | 16 | 0.040 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2018 | 224 | 0.040 |
Why?
| | Immunotherapy | 1 | 2022 | 641 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2022 | 1389 | 0.030 |
Why?
| | Codon | 1 | 2017 | 89 | 0.030 |
Why?
| | Exome | 1 | 2018 | 231 | 0.030 |
Why?
| | Peptides | 1 | 2022 | 985 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2022 | 916 | 0.030 |
Why?
| | T-Lymphocyte Subsets | 1 | 2018 | 417 | 0.030 |
Why?
| | Health Status Disparities | 1 | 2019 | 289 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2020 | 956 | 0.030 |
Why?
| | Child, Preschool | 2 | 2024 | 11074 | 0.030 |
Why?
| | Cell Survival | 1 | 2018 | 1120 | 0.030 |
Why?
| | Cytokines | 1 | 2022 | 2085 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2018 | 1142 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2014 | 282 | 0.030 |
Why?
| | Health Status Indicators | 1 | 2014 | 171 | 0.030 |
Why?
| | Observer Variation | 1 | 2014 | 343 | 0.030 |
Why?
| | Genotype | 1 | 2018 | 1916 | 0.030 |
Why?
| | Pandemics | 1 | 2021 | 1639 | 0.020 |
Why?
| | Brain | 1 | 2004 | 2668 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2014 | 565 | 0.020 |
Why?
| | Decision Making | 1 | 2014 | 900 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2014 | 1313 | 0.010 |
Why?
| | Neurosurgery | 1 | 2004 | 39 | 0.010 |
Why?
| | Guatemala | 1 | 2004 | 327 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2014 | 6079 | 0.010 |
Why?
| | Coronary Angiography | 1 | 2004 | 317 | 0.010 |
Why?
| | Anesthesia | 1 | 2004 | 189 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2004 | 2654 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2004 | 10811 | 0.000 |
Why?
|
|
Patel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|